World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
22074
World Ranking
1689
National Ranking
61

Ian G. Barr publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ian G. Barr sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 325 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ian G. Barr D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ian G. Barr sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ian G. Barr is affiliated with the University of Melbourne in Australia and has contributed extensively to the field of medicine, with a particular focus on epidemiology and infectious diseases. Their research spans several key subfields including immunology, modeling and simulation, as well as agronomy and crop science.

Their work addresses major topics such as influenza virus research studies, respiratory viral infections research, and viral infections and vectors. Other areas of focus include viral gastroenteritis research and epidemiology, COVID-19 epidemiological studies, animal disease management and epidemiology, and SARS-CoV-2 and COVID-19 research.

Among their recently published papers are the following:

  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis (2022) published in The Lancet
  • Off-season RSV epidemics in Australia after easing of COVID-19 restrictions (2022) published in Nature Communications
  • Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020 (2020) published in Eurosurveillance
  • Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination (2022) published in Nature Communications
  • Resurgence of avian influenza virus (2022) published in Science

Frequent co-authors who have collaborated with Ian G. Barr include:

  • Sheena G. Sullivan
  • Heidi Peck
  • Yi-Mo Deng
  • Benjamin J. Cowling
  • Kanta Subbarao

The scientist has published research in various venues, notably:

  • Influenza and Other Respiratory Viruses (23 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (16 publications)
  • Communicable Diseases Intelligence (6 publications)
  • Nature Communications (5 publications)
  • Emerging Infectious Diseases (5 publications)

Best Publications

  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

    Unknown

  • The Global Circulation of Seasonal Influenza A (H3N2) Viruses

    Colin A. Russell;Terry C. Jones;Terry C. Jones;Terry C. Jones;Ian G. Barr;Nancy J. Cox

  • Global circulation patterns of seasonal influenza viruses vary with antigenic drift.

    Trevor Bedford;Steven Riley;Ian G. Barr;Shobha Broor

  • Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

    Björn F. Koel;David F. Burke;Theo M. Bestebroer;Stefan van der Vliet

  • Antibody landscapes after influenza virus infection or vaccination

    J. M. Fonville;J. M. Fonville;J. M. Fonville;S. H. Wilks;S. H. Wilks;S. L. James;S. L. James;A. Fox

  • Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.

    Aeron C. Hurt;Joanne Ernest;Yi-Mo Deng;Pina Iannello

  • Efficacy of Soap and Water and Alcohol-Based Hand-Rub Preparations against Live H1N1 Influenza Virus on the Hands of Human Volunteers

    M Lindsay Grayson;M Lindsay Grayson;Sharmila Melvani;Julian D Druce;Ian G Barr

  • Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

    Unknown

  • Performance of six influenza rapid tests in detecting human influenza in clinical specimens

    Aeron C. Hurt;Aeron C. Hurt;Robert Alexander;Jan Hibbert;Nicola Deed

  • Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020

    Sheena G Sullivan;Sandra Carlson;Allen C Cheng;Monique Bn Chilver

  • Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses

    Colin A. Russell;Terry C. Jones;Terry C. Jones;Terry C. Jones;Ian G. Barr;Nancy J. Cox

  • Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation

    Aeron C. Hurt;Jessica K. Holien;Michael Parker;Michael Parker;Anne Kelso

  • ISCOMs and other saponin based adjuvants.

    JC Cox;A Sjölander;IG Barr

  • Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

    Aeron Christopher Giles Hurt;Paul Selleck;Naomi Komadina;Robert P Shaw

  • Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia.

    George G. Arzey;Peter D. Kirkland;K. Edla Arzey;Melinda Frost

  • Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

    Marios Koutsakos;Patricia T. Illing;Thi H. O. Nguyen;Nicole A. Mifsud

  • The contrasting phylodynamics of human influenza B viruses

    Dhanasekaran Vijaykrishna;Edward C. Holmes;Udayan Joseph;Mathieu Fourment

  • ISCOMs: an adjuvant with multiple functions.

    Anders Sjölander;John C. Cox;Ian G. Barr

  • 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.

    Mark I. C. Chen;Vernon J. M. Lee;Wei-Yen Lim;Ian G. Barr

  • Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia

    A. C. Hurt;K. Hardie;N. J. Wilson;Yi-Mo Deng

  • Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season

    Ian G Barr;John McCauley;Nancy Cox;Rod Daniels

  • Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis.

    Bruce C. Ross;Larissa Czajkowski;Dianna Hocking;Mai Margetts

  • MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Influenza Viruses Compared to Conventional MDCK Cells

    Ding Yuan Oh;Ian G Barr;Jennifer Anne Mosse;Karen L Laurie

  • Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses.

    Aeron C Hurt;Chantal Baas;Yi-Mo Deng;Sally Roberts

  • Multiple Infections with Seasonal Influenza A Virus Induce Cross-Protective Immunity against A(H1N1) Pandemic Influenza Virus in a Ferret Model

    Karen L. Laurie;Louise A. Carolan;Deborah Middleton;Sue Lowther

  • Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses

    Aeron C. Hurt;Jessica K. Holien;Michael W. Parker;Michael W. Parker;Ian G. Barr

  • ISCOMs (immunostimulating complexes): the first decade.

    Ian G Barr;Graham F Mitchell

  • Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity

    Carole Guillonneau;Justine D. Mintern;François Xavier Hubert;Aeron C. Hurt

Frequent Co-Authors

Aeron C. Hurt
Aeron C. Hurt Roche (Switzerland)
Anne Kelso
Anne Kelso University of Melbourne
Sebastian Maurer-Stroh
Sebastian Maurer-Stroh Agency for Science, Technology and Research
Sheena G. Sullivan
Sheena G. Sullivan World Health Organization
Raymond T. P. Lin
Raymond T. P. Lin National University of Singapore
Dhanasekaran Vijaykrishna
Dhanasekaran Vijaykrishna University of Hong Kong
Vernon J. Lee
Vernon J. Lee Ministry of Health
James M. McCaw
James M. McCaw University of Melbourne
Derek J. Smith
Derek J. Smith University of Cambridge
Yee Sin Leo
Yee Sin Leo Nanyang Technological University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, expanding your qualifications through related online degrees can open diverse career pathways in healthcare and research. Many professionals pursue specialized nursing roles that complement immunological expertise.

One popular route is advancing to a psychiatric nurse practitioner role. Exploring the cheapest pmhnp certificate programs provides insight into affordable options for online studies that can enhance your clinical and patient care skills.

If you are considering higher education, understanding the dnp salary by state is crucial. It helps gauge potential income in different regions for those obtaining a Doctor of Nursing Practice degree, a qualification that often boosts career prospects in immunology-related healthcare roles.

For nurses looking to specialize further, learning how to transition effectively from an FNP to acute care NP role is key. The guide on fnp to acute care np transitions offers practical advice for career shifts.

Finally, accelerated programs provide time-efficient paths for nurses aiming to advance quickly. Reviewing the accelerated np programs available online can help you choose options that fit your schedule while aligning with your immunology career goals.

Best Scientists Citing Ian G. Barr

Trending Scientists

Recently Published Articles